Another vasoconstrictor with the potential to exacerbate cerebral hypoperfusion in AD is angiotensin II (Ang II), cleaved from angiotensin I by the action of angiotensin‐converting enzyme (ACE), the level of which was found to be elevated in the frontal cortex in AD 31, 35. The gene discussed is AGT; the disease is Alzheimer disease.